Prognostic and predictive biomarkers with therapeutic targets in breast cancer: A 2022 update on current developments, evidence, and recommendations.

Chung, Clement; Yeung, Vanessa T Y; Wong, Kenneth C W

Chung, Clement; Yeung, Vanessa T Y; Wong, Kenneth C W.

Afiliação

Chung C; Department of Pharmacy, Houston Methodist West Hospital, Houston, TX, USA.
Yeung VTY; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR.
Wong KCW; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR.

J Oncol Pharm Pract ; 29(6): 1343-1360, 2023 Sep.

Article em En | MEDLINE | ID: mdl-35971313

Assuntos

Neoplasias da Mama; Humanos; Feminino; Prognóstico; Neoplasias da Mama/genética; Proteína BRCA1/genética; Instabilidade de Microssatélites; Biomarcadores Tumorais/genética; Biomarcadores Tumorais/metabolismo; Proteína BRCA2/genética

Palavras-chave

biomarkers; breast cancer; immune cancer therapy; predictive or prognostic; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: J Oncol Pharm Pract Assunto da revista: FARMACIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google